#ANTI-21B;(4R)-3-[[2S,3S,(4Z)]-5-[[[TERT.-BUTYL-(DIPHENYL)-SILYL]-OXY-METHYL]-3-HYDROXY-9-METHYL-2-(3-METHYL-BUT-3-ENYL)-DECA-4,8-DIENOYL]-4-ISOPROPYL-1,3-OXAZ
Compound with spectra: 1 NMR
![#ANTI-21B;(4R)-3-[[2S,3S,(4Z)]-5-[[[TERT.-BUTYL-(DIPHENYL)-SILYL]-OXY-METHYL]-3-HYDROXY-9-METHYL-2-(3-METHYL-BUT-3-ENYL)-DECA-4,8-DIENOYL]-4-ISOPROPYL-1,3-OXAZ](/api/compound/F1hZk45DTTq.png?ph=true&h=300&w=458 "#ANTI-21B;(4R)-3-[[2S,3S,(4Z)]-5-[[[TERT.-BUTYL-(DIPHENYL)-SILYL]-OXY-METHYL]-3-HYDROXY-9-METHYL-2-(3-METHYL-BUT-3-ENYL)-DECA-4,8-DIENOYL]-4-ISOPROPYL-1,3-OXAZ")
| SpectraBase Compound ID | F1hZk45DTTq |
|---|---|
| InChI | InChI=1S/C39H55NO5Si/c1-28(2)17-16-18-31(25-36(41)34(24-23-29(3)4)37(42)40-35(30(5)6)27-44-38(40)43)26-45-46(39(7,8)9,32-19-12-10-13-20-32)33-21-14-11-15-22-33/h10-15,17,19-22,25,30,34-36,41H,3,16,18,23-24,26-27H2,1-2,4-9H3/b31-25-/t34-,35-,36-/m0/s1 |
| InChIKey | CIWQXJVNGANTCZ-XTRWGVHNSA-N |
| Mol Weight | 646.0 g/mol |
| Molecular Formula | C39H55NO5Si |
| Exact Mass | 645.38495 g/mol |
| Enantiomer InChIKey | CIWQXJVNGANTCZ-BNAYDBJASA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD2Cl2 |
#SYN-21B;(4R)-3-[[2R,3S,(4Z)]-5-[[[TERT.-BUTYL-(DIPHENYL)-SILYL]-OXY-METHYL]-3-HYDROXY-9-METHYL-2-(3-METHYL-BUT-3-ENYL)-DECA-4,8-DIENOYL]-4-ISOPROPYL-1,3-OXAZO
#5B;(4R)-3-[[2R,3S,(4E)]-5-[[[TERT.-BUTYL-(DIPHENYL)-SILYL]-OXY]-METHYL]-3-HYDROXY-9-METHYL-2-(3-METHYL-BUT-3-ENYL)-DECA-4,8-DIENOYL]-4-ISOPROPYL-1,3-OXAZOLIDI
[1R,(2Z)]-1-[(1S)-1-[[(4S)-4-ISOPROPYL-2-OXO-1,3-OXAZOLIDIN-3-YL]-CARBONYL]-4-METHYL-PENT-4-ENYL]-3,7-DIMETHYL-OCTA-2,6-DIENYL-4-BROMOBENZOATE
2-[5-[[4-(benzyloxy)phenyl]-hydroxy-methyl]-6-(4-isopropyl-2-keto-oxazolidin-3-yl)-6-keto-hexyl]isoindoline-1,3-quinone
(4S)-3-[(2S,4R)-2-TERT.-BUTOXYCARBONYLAMINO-5-TERT.-BUTYLDIPHENYLSILYLOXY-4-METHYLPENTANOYL]-4-PHENYL-2-OXAZOLIDINONE
2,2-[(2R,3S)-3-[[(4S)-4-(Methylethyl)-2-oxo-3-oxazolidinyl]carbonyl]-2-(3-bromopropyl)-1-oxa-1,4-butanediyl]-1,3-dithiane
#9A;ANTI-(2S,3S)-3-(3-TERT.-BUTYLDIPHENYLSILYLOXYPROPYL)-1-[(2S)-2-(METHOXYCARBONYL)-PYRROLIDIN-1-YL]-2-[(E)-2-(3-METHOXYPHENYL)-ETHENYL]-4-METHYL-4-PENTENONE-
#8A;ANTI-(2R,3R)-3-(3-TERT.-BUTYLDIPHENYLSILYLOXYPROPYL)-1-[(2S)-2-(METHOXYCARBONYL)-PYRROLIDIN-1-YL]-2-[(E)-2-(3-METHOXYPHENYL)-ETHENYL]-4-METHYL-4-PENTENONE-
#8H;MAJOR-(2,3-ANTI):(2R,3R)-3-(3-TERT.-BUTYLDIPHENYLSILYLOXYPROPYL)-1-[(2S,4R)-4-METHOXY-2-(METHOXYMETHYL)-PYRROLIDIN-1-YL]-2-[(E)-2-(3-METHOXYPHENYL)-ETHENYL
#10H;(2,3-SYN-1):(2R,3S)-3-(3-TERT.-BUTYLDIPHENYLSILYLOXYPROPYL)-1-[(2S,4R)-4-METHOXY-2-(METHOXYMETHYL)-PYRROLIDIN-1-YL]-2-[(E)-2-(3-METHOXYPHENYL)-ETHENYL]-4-
| Title | Journal or Book | Year |
|---|---|---|
| Asymmetric Evans syn‐Aldol Reactions of Terpene‐Derived Enals: Scope and Limitations | European Journal of Organic Chemistry | 2014 |